Multiple Cardiac Sensors for the Management of Heart Failure

Inclusion Criteria

• •1. Subject is age 18 or above, or of legal age to give informed consent
• •2. Implanted with an cardiac resynchronization therapy defibrillator (CRT-D) or implantable cardioverter-defibrillator (ICD) device that has HeartLogic
• •3. Current symptomatic heart failure or New York Heart Association Class II or III at the time of enrollment
• •4. Remotely monitored by LATITUDE 5.0 (or future versions)
• •5. Willing and capable of participating in all study visits and complying with medication/treatment requirements associated with this clinical study at an approved clinical study center.
• •6. Meet at least one of the three following conditions:
• •* At least one documented hospitalization with a primary diagnosis of worsening for heart failure during the 12 months prior to enrollment; or
• •* Unscheduled outpatient visit with IV diuretic therapy for acute worsening of HF during 90 days prior to enrollment; or
• •* N-terminal-pro brain natriuretic peptide (NT-proBNP) greater than 600 pg/mL or brain natriuretic peptide (BNP) greater than 150 pg/mL at any time during 90 days prior to enrollment